Search research articles
Contact Us
Filters
Showing results (51-60 of 125) with videos related to
Page
of 13
Sort By:
Food & Function
|
January 18, 2020
Consumption of a green tea extract-curcumin drink decreases blood urea nitrogen and redox iron in β-thalassemia patients
Pimpisid Koonyosying, Adisak Tantiworawit, Sasinee Hantrakool, et al.
European Journal of Internal Medicine
|
November 8, 2015
Development of a new disease severity scoring system for patients with non-transfusion-dependent thalassemia
M Domenica Cappellini, John B Porter, Khaled M Musallam, et al.
Hemasphere
|
March 6, 2025
TIF Guidelines for the Management of Transfusion-Dependent β-Thalassemia
Khaled M Musallam, Maria Domenica Cappellini, John B Porter, et al.
British Journal of Haematology
|
January 17, 2017
Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects
Bernard A Davis, Shubha Allard, Amrana Qureshi, et al.
British Journal of Haematology
|
December 6, 2016
Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions
John B Porter, Maria Domenica Cappellini, Antonis Kattamis, et al.
British Journal of Haematology
|
October 7, 2021
Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias
Farrukh T Shah, John B Porter, Nandini Sadasivam, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
July 20, 2005
Left ventricular diastolic function compared with T2* cardiovascular magnetic resonance for early detection of myocardial iron overload in thalassemia major
Mark A Westwood, Beatrix Wonke, Alicia M Maceira, et al.
British Journal of Haematology
|
September 13, 2012
Prospective study of histomorphometry, biochemical bone markers and bone densitometric response to pamidronate in β-thalassaemia presenting with osteopenia-osteoporosis syndrome
Ratna Chatterjee, Farrukh T Shah, Bernard A Davis, et al.
Blood
|
June 6, 2003
Deferiprone and hepatic fibrosis
Gary M Brittenham, David G Nathan, Nancy F Olivieri, et al.
Gastroenterology
|
July 12, 2011
Improvement in liver pathology of patients with β-thalassemia treated with deferasirox for at least 3 years
Yves Deugnier, Bruno Turlin, Martine Ropert, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 125) with videos related to
Sort By:
Page
of 13
Food & Function
|
January 18, 2020
Consumption of a green tea extract-curcumin drink decreases blood urea nitrogen and redox iron in β-thalassemia patients
Pimpisid Koonyosying, Adisak Tantiworawit, Sasinee Hantrakool, et al.
European Journal of Internal Medicine
|
November 8, 2015
Development of a new disease severity scoring system for patients with non-transfusion-dependent thalassemia
M Domenica Cappellini, John B Porter, Khaled M Musallam, et al.
Hemasphere
|
March 6, 2025
TIF Guidelines for the Management of Transfusion-Dependent β-Thalassemia
Khaled M Musallam, Maria Domenica Cappellini, John B Porter, et al.
British Journal of Haematology
|
January 17, 2017
Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects
Bernard A Davis, Shubha Allard, Amrana Qureshi, et al.
British Journal of Haematology
|
December 6, 2016
Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions
John B Porter, Maria Domenica Cappellini, Antonis Kattamis, et al.
British Journal of Haematology
|
October 7, 2021
Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias
Farrukh T Shah, John B Porter, Nandini Sadasivam, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
July 20, 2005
Left ventricular diastolic function compared with T2* cardiovascular magnetic resonance for early detection of myocardial iron overload in thalassemia major
Mark A Westwood, Beatrix Wonke, Alicia M Maceira, et al.
British Journal of Haematology
|
September 13, 2012
Prospective study of histomorphometry, biochemical bone markers and bone densitometric response to pamidronate in β-thalassaemia presenting with osteopenia-osteoporosis syndrome
Ratna Chatterjee, Farrukh T Shah, Bernard A Davis, et al.
Blood
|
June 6, 2003
Deferiprone and hepatic fibrosis
Gary M Brittenham, David G Nathan, Nancy F Olivieri, et al.
Gastroenterology
|
July 12, 2011
Improvement in liver pathology of patients with β-thalassemia treated with deferasirox for at least 3 years
Yves Deugnier, Bruno Turlin, Martine Ropert, et al.
Page
of 13